Macimorelinacetate (1) – Gryvelin®
Hypohysis function tests
Characteristics
| Start date | 14.04.2022 |
|---|---|
| Resolution | 19.05.2022 |
| INN | Macimorelinacetate |
| Brand name | Gryvelin® |
| Pharm. company | Consilient Health Ltd. |
| G-BA Procedure ID | F-001w |
| Therapeutic area | Other diseases |
| Reason for procedure | not completed: exempted |
Associated procedures
<< List of all resolutions